Health Condition 1: H259- Unspecified age-related cataract
Conditions
Interventions
Intervention1: Topical medication, loteprednol and prednisolone will be prescribed post phacoemulsification: Two groups of patients in our study. One group will receive loteprednol and the other group
Sponsors
Sankara eye hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patient with age related cataract Patients in the age between 40 and 80 years Patient willing to give consent for study and follow up
Exclusion criteria
Exclusion criteria: Patient with diabetes mellitus. Patient with mature, hypermature, traumatic and complicated cataract. Patient with history of autoimmune disorders, chronic inflammatory disorders. Patient with immunodeficiency status. Patient on treatment for elevated IOP, on oral steroids, immunomodulatory therapy, on oral non steroidal anti-inflammatory drugs (NSAIDs). Patients with pseudoexfoliation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the control of ocular inflammation after phacoemulsification in patients treated with loteprednol etabonate 1% and prednisolone acetate 1%Timepoint: At post-operative week 1, 3 and 6 | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess IOP changes in patients treated with the loteprednol etabonate 1% and prednisolone acetate 1%.Timepoint: At post-operative week 1, 3 and 6 | — |
Countries
India
Contacts
Public ContactDr Mahesha S
Sankara eye hospital, Shimoga
Outcome results
None listed